Quinuclidine derivatives and their use as muscarinic M3 receptor antagonists

Details for Australian Patent Application No. 2005300710 (hide)

Owner Novartis AG

Inventors Collingwood, Stephen Paul; Papoutsakis, Dimitris; Cox, Brian; Kim, Hyungchul; Baettig, Urs; Watson, Simon James; Garad, Sudhakar Devidasrao; Press, Neil John

Agent Davies Collison Cave

Pub. Number AU-B-2005300710

PCT Pub. Number WO2006/048225

Priority 0424284.8 02.11.04 GB

Filing date 31 October 2005

Wipo publication date 11 May 2006

Acceptance publication date 14 May 2009

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/048225 Priority application(s): WO2006/048225

14 May 2009 Application Accepted

  Published as AU-B-2005300710

10 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005300725-Device for the treatment of wounds using a vacuum

2005300707-Distributor connection module